-
Product Insights
NewAminopeptidase N – Drugs In Development, 2024
The Aminopeptidase N pipeline drugs market research report outlays comprehensive information on the Aminopeptidase N targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Central Nervous System, Immunology, and Ophthalmology which include indications of Malignant Pleural Mesothelioma, Fibrosarcoma, Post-Operative Pain, Ocular Pain (Eye Pain), Graft Versus Host Disease (GVHD), and Keratoconjunctivitis Sicca (Dry Eye). It also reviews...
-
Product Insights
NewNicotinamide N Methyltransferase – Drugs In Development, 2024
The Nicotinamide N Methyltransferase pipeline drugs market research report outlays comprehensive information on the Nicotinamide N Methyltransferase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Musculoskeletal Disorders, Metabolic Disorders, Oncology, and Gastrointestinal which include indications of Musculoskeletal Disorders, Sarcopenia, Obesity, Type 2 Diabetes, Solid Tumor, Glioblastoma Multiforme (GBM), and Metabolic Dysfunction-Associated Steatohepatitis (MASH). It also reviews key...
-
Product Insights
NewN Sulphoglucosamine Sulphohydrolase – Drugs In Development, 2024
The N Sulphoglucosamine Sulphohydrolase pipeline drugs market research report outlays comprehensive information on the N Sulphoglucosamine Sulphohydrolase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Metabolic Disorders which include indications of Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ). It also reviews key players involved in N Sulphoglucosamine Sulphohydrolase targeted therapeutics development with respective active and dormant or...
-
Product Insights
NewAlpha N-Acetylglucosaminidase – Drugs In Development, 2024
The Alpha N-Acetylglucosaminidase pipeline drugs market research report outlays comprehensive information on the Alpha N-Acetylglucosaminidase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Metabolic Disorders which include indications of Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ). It also reviews key players involved in Alpha N-Acetylglucosaminidase targeted therapeutics development with respective active and dormant or discontinued projects. Note:...
-
Product Insights
NewHistone Lysine N Methyltransferase EZH2 – Drugs In Development, 2024
The Histone Lysine N Methyltransferase EZH2 pipeline drugs market research report outlays comprehensive information on the Histone Lysine N Methyltransferase EZH2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, and Infectious Disease which include indications of Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, and Respiratory Syncytial Virus (RSV) Infections. It also reviews key players involved in Histone...
-
Product Insights
NewN-Formyl Peptide Receptor 2 – Drugs In Development, 2024
The N-Formyl Peptide Receptor 2 pipeline drugs market research report outlays comprehensive information on the N-Formyl Peptide Receptor 2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Cardiovascular, Central Nervous System, Respiratory, and Immunology which include indications of Myocardial Infarction, Atherosclerosis, Alzheimer's Disease, Multiple Sclerosis, Asthma, Acute Respiratory Distress Syndrome, Rheumatoid Arthritis, and Inflammation. It also reviews...
-
Product Insights
NewN Myc Proto Oncogene Protein – Drugs In Development, 2024
The N Myc Proto Oncogene Protein pipeline drugs market research report outlays comprehensive information on the N Myc Proto Oncogene Protein targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology which include indications of Neuroblastoma, and Medulloblastoma. It also reviews key players involved in N Myc Proto Oncogene Protein targeted therapeutics development with respective active and dormant...
-
Product Insights
NewHistone Lysine N Methyltransferase EZH1 – Drugs In Development, 2024
The Histone Lysine N Methyltransferase EZH1 pipeline drugs market research report outlays comprehensive information on the Histone Lysine N Methyltransferase EZH1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, and Infectious Disease which include indications of Diffuse Large B-Cell Lymphoma, Solid Tumor, and Respiratory Syncytial Virus (RSV) Infections. It also reviews key players involved in Histone...
-
Product Insights
NewProtein Arginine N Methyltransferase 5 – Drugs In Development, 2024
The Protein Arginine N Methyltransferase 5 pipeline drugs market research report outlays comprehensive information on the Protein Arginine N Methyltransferase 5 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, and Hematological Disorders which include indications of Solid Tumor, Non-Small Cell Lung Cancer, and Unspecified Hematological Disorders. It also reviews key players involved in Protein Arginine N...
-
Product Insights
NewUDP-3-O-[3-Hydroxymyristoyl] N-Acetylglucosamine Deacetylase – Drugs In Development, 2024
The UDP-3-O-[3-Hydroxymyristoyl] N-Acetylglucosamine Deacetylase pipeline drugs market research report outlays comprehensive information on the UDP-3-O-[3-Hydroxymyristoyl] N-Acetylglucosamine Deacetylase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Infectious Disease, Respiratory, and Genito Urinary System which include indications of Pseudomonas aeruginosa Infections, Klebsiella pneumoniae Infections, Lung Infections, and Urinary Tract Infections. It also reviews key players involved in UDP-3-O-[3-Hydroxymyristoyl] N-Acetylglucosamine...